Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Parasitic Diseases

  Free Subscription


Articles published in Parasite Immunol

Retrieve available abstracts of 41 articles:
HTML format
Text format



Single Articles


    September 2017
  1. SANCHEZ MV, Elicabe RJ, Di Genaro MS, Germano MJ, et al
    Total Leishmania antigens with Poly(I:C) induce Th1 protective response.
    Parasite Immunol. 2017 Sep 13. doi: 10.1111/pim.12491.
    PubMed     Text format     Abstract available


    August 2017
  2. MARCONATO DG, do Nascimento Gusmao MA, Melo J, de Andrade Castro JM, et al
    Anti-schistosome antibodies change NTPDase 1 activity from macrophages.
    Parasite Immunol. 2017 Aug 30. doi: 10.1111/pim.12487.
    PubMed     Text format     Abstract available


  3. MONTAKHAB-YEGANEH H, Abdossamadi Z, Zahedifard F, Taslimi Y, et al
    Leishmania tarentolae expressing CXCL-10 as an efficient immunotherapy approach against L. major-infected BALB/c mice.
    Parasite Immunol. 2017 Aug 18. doi: 10.1111/pim.12461.
    PubMed     Text format     Abstract available


    July 2017
  4. BADIRZADEH A, Taheri T, Abedi-Astaneh F, Taslimi Y, et al
    Arginase activity of Leishmania isolated from patients with cutaneous leishmaniasis.
    Parasite Immunol. 2017 Jul 21. doi: 10.1111/pim.12454.
    PubMed     Text format     Abstract available


  5. BUJARBARUAH D, Kalita MP, Baruah V, Basumatary TK, et al
    RANTES levels as a determinant of falciparum malaria severity or recovery.
    Parasite Immunol. 2017 Jul 7. doi: 10.1111/pim.12452.
    PubMed     Text format     Abstract available


    June 2017
  6. DIKHIT MR, Amit A, Singh AK, Kumar A, et al
    Vaccine potential of HLA A2 epitopes from Leishmania Cysteine Protease Type III (CPC).
    Parasite Immunol. 2017 Jun 30. doi: 10.1111/pim.12451.
    PubMed     Text format     Abstract available


    May 2017
  7. NYHALAH DJ, Dobgima GS, Titanji VP
    Enhanced acquired antibodies to a chimeric Plasmodium falciparum antigen; UB05-09 is associated with protective immunity against malaria.
    Parasite Immunol. 2017 May 24. doi: 10.1111/pim.12445.
    PubMed     Text format     Abstract available


  8. RODRIGUEZ NE, Lockard RD, Turcotte EA, Araujo-Santos T, et al
    Lipid bodies accumulation in Leishmania infantum-infected C57BL/6 macrophages.
    Parasite Immunol. 2017 May 18. doi: 10.1111/pim.12443.
    PubMed     Text format     Abstract available


    April 2017
  9. MOREIRA RB, Pirmez C, De Oliveira-Neto MP, De Souza Aguiar L, et al
    AIM2 inflammasome is associated to disease severity in tegumentary leishmaniasis caused by Leishmania (V.) braziliensis.
    Parasite Immunol. 2017 Apr 11. doi: 10.1111/pim.12435.
    PubMed     Text format     Abstract available


  10. BOSTROM S, Schmiegelow C, Abu Abed U, Minja DT, et al
    Neutrophil alterations in pregnancy associated malaria and induction of neutrophil chemotaxis by Plasmodium falciparum.
    Parasite Immunol. 2017 Apr 5. doi: 10.1111/pim.12433.
    PubMed     Text format     Abstract available


    March 2017
  11. SALIH MA, Fakiola M, Lyons PA, Younis BM, et al
    Expression profiling of Sudanese visceral leishmaniasis patients pre- and post-treatment with sodium stibogluconate.
    Parasite Immunol. 2017 Mar 31. doi: 10.1111/pim.12431.
    PubMed     Text format     Abstract available


    February 2017
  12. GOMES AH, Martines RB, Kanamura CT, Barbo ML, et al
    American cutaneous leishmaniasis: In situ immune response of patients with recent and late lesions.
    Parasite Immunol. 2017 Feb 26. doi: 10.1111/pim.12423.
    PubMed     Text format     Abstract available


  13. PEDRAZA-ZAMORA CP, Delgado-Dominguez J, Zamora-Chimal J, Becker I, et al
    Th17 cells and neutrophils: close collaborators in chronic Leishmania mexicana infections leading to disease severity.
    Parasite Immunol. 2017 Feb 16. doi: 10.1111/pim.12420.
    PubMed     Text format     Abstract available


  14. HONG Y, Fu Z, Cao X, Lin J, et al
    Changes in microRNA expression in response to Schistosoma japonicum infection.
    Parasite Immunol. 2017 Feb 4. doi: 10.1111/pim.12416.
    PubMed     Text format     Abstract available


    January 2017
  15. MANAMPERI NH, Oghumu S, Pathirana N, de Silva VC, et al
    In situ immunopathological changes in cutaneous leishmaniasis due to Leishmania donovani.
    Parasite Immunol. 2017 Jan 23. doi: 10.1111/pim.12413.
    PubMed     Text format     Abstract available


  16. MUNOZ-CARRILLO JL, Munoz-Escobedo JJ, Maldonado-Tapia CH, Chavez-Ruvalcaba F, et al
    Resiniferatoxin lowers TNF-alpha, NO and PGE2 in the intestinal phase and the parasite burden in the muscular phase of Trichinella spiralis infection.
    Parasite Immunol. 2017;39.
    PubMed     Text format     Abstract available


    November 2016
  17. SOUZA DM, Alves PM, Silva ML, Paulino TP, et al
    5-ALA-mediated Photodynamic Therapy Reduces the Parasite Load in Mice Infected with Leishmania braziliensis.
    Parasite Immunol. 2016 Nov 25. doi: 10.1111/pim.12403.
    PubMed     Text format     Abstract available


    October 2016
  18. NADY S, Shata MT, Mohey MA, El-Shorbagy A, et al
    Protective Role of IL-22 against Schistosoma mansoni Soluble Egg Antigen- Induced Granuloma in Vitro.
    Parasite Immunol. 2016 Oct 14. doi: 10.1111/pim.12392.
    PubMed     Text format     Abstract available


    September 2016
  19. MARTINS VT, Duarte MC, Lage DP, Costa LE, et al
    A recombinant chimeric protein composed by human and mice-specific CD4+ and CD8+ T cell epitopes protects against visceral leishmaniasis.
    Parasite Immunol. 2016 Sep 4. doi: 10.1111/pim.12359.
    PubMed     Text format     Abstract available


  20. BAGIROVA M, Allahverdiyev AM, Abamor ES, Ullah I, et al
    Overview of dendritic cell-based vaccine development for leishmaniasis.
    Parasite Immunol. 2016 Sep 3. doi: 10.1111/pim.12360.
    PubMed     Text format     Abstract available


    August 2016
  21. MORTAZAVIDEHKORDI N, Farjadfar A, Khanahmad H, Ghayour Najafabadi Z, et al
    Evaluation of a novel lentiviral vaccine expressing KMP11-HASPB fusion protein against Leishmania infantum in BALB/c mice.
    Parasite Immunol. 2016 Aug 19. doi: 10.1111/pim.12356.
    PubMed     Text format     Abstract available


  22. VENTURIN GL, Chiku VM, Silva KL, de Almeida BF, et al
    M1 polarization and the effect of PGE2 on TNF-alpha production by lymph node cells from dogs with visceral leishmaniasis.
    Parasite Immunol. 2016 Aug 10. doi: 10.1111/pim.12353.
    PubMed     Text format     Abstract available


  23. CHEN Q, Liang W, Qian F, Qian B, et al
    Rice-produced MSP142 of Plasmodium falciparum elicits antibodies that inhibit parasite growth in vitro.
    Parasite Immunol. 2016 Aug 5. doi: 10.1111/pim.12352.
    PubMed     Text format     Abstract available


    July 2016
  24. SHIVAHARE R, Ali W, Singh US, Natu SM, et al
    Immuno-protective effect of lentinan in combination with miltefosine on Leishmania infected J-774A.1 macrophages.
    Parasite Immunol. 2016 Jul 8. doi: 10.1111/pim.12346.
    PubMed     Text format     Abstract available


    June 2016
  25. PIRDEL L, Zavaran Hosseini A
    Immune response to recombinant Leishmania infantum Lipophosphoglycan 3 plus CpG oligodeoxynucleotides in BALB/c mice.
    Parasite Immunol. 2016 Jun 29. doi: 10.1111/pim.12345.
    PubMed     Text format     Abstract available


    May 2016
  26. HEIDARI-KHARAJI M, Taheri T, Doroud D, Habibzadeh S, et al
    Enhanced paromomycin efficacy by Solid Lipid Nanoparticle formulation against Leishmania in mice model.
    Parasite Immunol. 2016 May 23. doi: 10.1111/pim.12340.
    PubMed     Text format     Abstract available


  27. CHEN L, Chen Y, Zhang D, Hou M, et al
    Protection and immunological study on two tetraspanin-derived vaccine candidates against schistosomiasis japonicum.
    Parasite Immunol. 2016 May 18. doi: 10.1111/pim.12338.
    PubMed     Text format     Abstract available


  28. TWEYONGYERE R, Namanya H, Naniima P, Cose S, et al
    Human eosinophils modulate peripheral blood mononuclear cell response to Schistosoma mansoni adult worm antigen in vitro.
    Parasite Immunol. 2016 May 12. doi: 10.1111/pim.12336.
    PubMed     Text format     Abstract available


    April 2016
  29. GERALDO MM, Costa CR, Barbosa FM, Vivanco BC, et al
    In vivo and in vitro phagocytosis of Leishmania (Leishmania) amazonensis promastigotes by B-1 cells.
    Parasite Immunol. 2016 Apr 16. doi: 10.1111/pim.12324.
    PubMed     Text format     Abstract available


  30. DINKO B, King E, Targett GA, Sutherland CJ, et al
    Antibody responses to surface antigens of Plasmodium falciparum gametocyte-infected erythrocytes and their relation to gametocytaemia.
    Parasite Immunol. 2016 Apr 16. doi: 10.1111/pim.12323.
    PubMed     Text format     Abstract available


    March 2016
  31. MANDALA WL, Msefula CL, Gondwe EN, Drayson MT, et al
    Monocyte activation and cytokine production in Malawian children presenting with P. falciparum malaria.
    Parasite Immunol. 2016 Mar 30. doi: 10.1111/pim.12319.
    PubMed     Text format     Abstract available


  32. DINGA JN, Njimoh DL, Kiawa B, Djikeng A, et al
    Differential T-cell responses to a chimeric Plasmodium falciparum antigen; UB05-09, correlates with acquired immunity to malaria.
    Parasite Immunol. 2016 Mar 25. doi: 10.1111/pim.12318.
    PubMed     Text format     Abstract available


  33. KAUFFMANN F, Dumetz F, Hendrickx S, Muraille E, et al
    In vivo characterization of two additional Leishmania donovani strains using the murine and hamster model.
    Parasite Immunol. 2016 Mar 25. doi: 10.1111/pim.12316.
    PubMed     Text format     Abstract available


  34. KUMAR A, Samant M
    DNA vaccine against visceral leishmaniasis: a promising approach for prevention & control.
    Parasite Immunol. 2016 Mar 24. doi: 10.1111/pim.12315.
    PubMed     Text format     Abstract available


  35. CUNHA CF, Ferraz R, Pimentel MI, Lyra MR, et al
    Cytotoxic cell involvement in human cutaneous leishmaniasis: assessments in active disease, under therapy and after clinical cure.
    Parasite Immunol. 2016 Mar 1. doi: 10.1111/pim.12312.
    PubMed     Text format     Abstract available


  36. DIAZ A, Casaravilla C, Barrios AA, Ferreira AM, et al
    Parasite molecules and host responses in cystic echinococcosis.
    Parasite Immunol. 2016;38:193-205.
    PubMed     Text format     Abstract available


    February 2016
  37. MASPI N, Ghaffarifar F, Sharifi Z, Dalimi A, et al
    Co-delivery of DNA vaccination encoding LeIF gene and IL-12 increases protection against Leishmania major infection in BALB/c mice.
    Parasite Immunol. 2016 Feb 12. doi: 10.1111/pim.12310.
    PubMed     Text format     Abstract available


    January 2016
  38. NATEGHI ROSTAMI M, Seyyedan Jasbi E, Khamesipour A, Mohammadi AM, et al
    Tumor Necrosis Factor-alpha (TNF-alpha) and its soluble receptor type 1 (sTNFR I) in human active and healed leishmaniasis.
    Parasite Immunol. 2016 Jan 27. doi: 10.1111/pim.12305.
    PubMed     Text format     Abstract available


  39. MARTINS VT, Lage DP, Duarte MC, Costa LE, et al
    Cross-protective efficacy from a immunogen firstly identified in Leishmania infantum against tegumentary leishmaniasis.
    Parasite Immunol. 2016 Jan 12. doi: 10.1111/pim.12304.
    PubMed     Text format     Abstract available


    December 2015
  40. PRENDERGAST CT, Sanin DE, Mountford AP
    CD4 T cell hypo-responsiveness induced by schistosome larvae is not dependent upon eosinophils but may involve connective tissue mast cells.
    Parasite Immunol. 2015 Dec 17. doi: 10.1111/pim.12300.
    PubMed     Text format     Abstract available


    September 2015
  41. FONTANA MF, Baccarella A, Kellar D, Oniskey TK, et al
    Myeloid expression of the AP-1 transcription factor JUNB modulates outcomes of type 1 and type 2 parasitic infections.
    Parasite Immunol. 2015;37:470-8.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Parasitic Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: